This grant funds projects to further develop and validate innovative technologies that advance cancer research or clinical care, focusing on technical improvements and rigorous validation for broad adoption.
This grant funds early-stage, highly innovative technology development for improving analysis and handling of biospecimens in basic or clinical cancer research, focusing on proof-of-concept studies.
This grant funds early-stage, highly innovative technology development projects to improve cancer research or clinical care, focusing on proof-of-concept studies with high potential impact in cancer-related fields.
The National Cancer Institute will soon invite applications to develop innovative, user-friendly informatics technologies that advance cancer research, spanning early tool development to initial dissemination.
This grant funds the validation of molecular, cellular, and imaging biomarkers and assays for cancer detection, diagnosis, prognosis, treatment response, and prevention, supporting both analytical and clinical validation phases.